BN Business News
Add your company to Business Communicator →

Business · 11/09/2019Updated: 10/17/2026 · 1 min read

FDA to Hold Public Hearing on Fecal Microbiota Transplantation for C. difficile Infection

Summary

The FDA is seeking public input on the use of fecal microbiota transplantation to treat C. difficile infections that are not responsive to standard therapies, as part of its ongoing consideration of this treatment approach.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →